Cetuximab Monotherapy Maintenance Treatment in mCRC
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Investigating the efficacy of Cetuximab Monotherapy versus Continuation after induction treatment with chemotherapy + Cetuximab in inoperable or irresectable and non-progressive metastatic colorectal cancer after first line induction treatment for 24 weeks with mFOLFOX6/FOLFIRI and Cetuximab treatment. Reinduction treatment will be done in case of progression.
创建时间：
2016-11-15
